Duration and intensity of tobacco smoking and the risk of papillary and non-papillary transitional cell carcinoma of the bladder

Cancer Causes and Control

Volumn 25, Issue 9, 2014, Pages 1151-1158

  Polesel, Jerry ^a   Bosetti, Cristina ^b   di Maso, Matteo ^a   Montella, Maurizio ^c   Libra, Massimo ^d   Garbeglio, Antonio ^e   Zucchetto, Antonella ^a,f   Turati, Federica ^b   Talamini, Renato ^a   La Vecchia, Carlo ^f   Serraino, Diego ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d UNIVERSITY OF CATANIA   (Italy)

^e S MARIA DEGLI ANGELI HOSPITAL   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

Author keywords

Bladder; Papillary; Risk; Tobacco smoking; Transitional cell carcinoma

Indexed keywords

ADOLESCENT; ADULT; ADVERSE EFFECTS; AGED; CARCINOMA, TRANSITIONAL CELL; CASE CONTROL STUDY; FEMALE; HUMAN; ITALY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PATHOLOGY; RISK FACTOR; SMOKING; STATISTICAL MODEL; URINARY BLADDER NEOPLASMS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CARCINOMA, TRANSITIONAL CELL; CASE-CONTROL STUDIES; FEMALE; HUMANS; ITALY; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; RISK FACTORS; SMOKING; URINARY BLADDER NEOPLASMS; YOUNG ADULT;

EID: 84939891617     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-014-0416-0     Document Type: Article

References (27)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) GLOBOCAN 2008 v2.0. Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. International Agency for Research on Cancer: Lyon, France. Available from: http://globocan.iarc.fr, accessed on 13/01/2014
2. Silverman BT, Devesa SS, Moore LE, Rothman N (2006) Bladder cancer. Cancer epidemiology and prevention, 3rd edn. Oxford Univ Press, New York
3. Eble JN, Sauter G, Epstein JI, Sesterhenn IAD (eds) (2004) World health organization classification of tumours. Tumours of the urinary system and genital male organs. IARC Press, Lyon
4. IARC (2004) IARC monographs on the evaluation of carcinogenic risks to Humans, Vol 83. Tobacco smoke and involuntary smoking. IARC Sci Publ. Lyon: IARC
5. Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC (2011) Association between smoking and risk of bladder cancer among men and women. JAMA 306:737–745
6. Brennan P, Bogilot O, Cordier S et al (2000) Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case–control studies. Int J Cancer 86:289–294
7. Samanic C, Kogevinas M, Dosemici M et al (2006) Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and gender. Cancer Epidemiol Biomark Prev 15:1348–1354
8. Baris D, Karagas MR, Verrill C et al (2009) A case–control study of smoking and bladder cancer risk: emergent patterns over time. J Natl Cancer Inst 101:1553–1561
9. Hinotsu S, Akaza H, Miki T et al (2009) Bladder cancer develops 6 years earlier in current smokers: analysis of bladder cancer registry data by the cancer registration committee of the Japanese urological association. Int J Urol 16:64–69
10. Pietzak EJ, Malkowicz (2014) Does quantification of smoking history correlate with initial bladder tumor grade and stage? Curr Urol Rep. 15:416. doi: 10.1007/s11934-014-0416-3
11. Jiang X, Castelao JE, Yuan JM et al (2012) Cigarette smoking and subtype of bladder cancer. Int J Cancer 130:896–901
12. Sturgeon SR, Hartge P, Silverman DT et al (1994) Association between bladder cancer risk factors and tumor stage and grade at diagnosis. Epidemiology 5:218–225
13. Polesel J, Gheit T, Talamini R et al (2012) Urinary human polyomavirus and papillomavirus infection and bladder cancer risk. Br J Cancer 106:222–226
14. D’Avanzo B, La Vecchia C, Katsouyanni K, Negri E, Trichopoulos D (1996) Reliability of information on cigarette smoking and beverage consumption provided by hospital controls. Epidemiology 7:312–315
15. Breslow NE, Day NE (1980) Statistical methods in cancer research, vol 1. The analysis of case–control studies. IARC Sci Publ No. 32. IARC: Lyon
16. Benichou J (1991) Methods of adjustment for estimating the attributable risk in case–control studies: a review. Stat Med 10:1753–1773
17. Bjerregaard BK, Raaschou-Nielsen O, Sørensen M et al (2006) Tobacco smoke and bladder cancer—in the European prospective investigation into cancer and nutrition. Int J Cancer 119:2412–2416
18. Augustine A, Hebert JR, Kabat GC, Wynder EL (1988) Bladder cancer in relation to cigarette smoking. Cancer Res 48:4405–4408
19. Hartge P, Silverman DT, Schairer C, Hoover RN (1993) Smoking and bladder cancer risk in blacks and whites in the United States. Cancer Cause Control 4:391–394
20. Chiu BCH, Lynch CF, Cerhan JR, Cantor KP (2001) Cigarette smoking and risk of bladder, pancreas, kidney, and colorectal cancer in Iowa. Ann Epidemiol 11:28–37
21. Castelao JE, Yuan JM, Skipper PL et al (2001) Gender- and smoking-related bladder cancer risk. J Natl Cancer Inst 93:538–545
22. Puente D, Hartge P, Greiser E et al (2006) A pooled analysis of bladder cancer case–control studies evaluating smoking in men and women. Cancer Causes Control 17:71–79
23. Lubin JH, Alavanja MC, Caporaso N et al (2007) Cigarette smoking and cancer risk: modelling total exposure and intensity. Am J Epidemiol 166:479–489
24. Hecht SS (2002) Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol 3:461–469
25. Hecht SS (2003) Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer 3:733–744
26. Sanderson S, Salanti G, Higgins J (2007) Joint effects of the N-Acetyltransferase 1 and 2 (NAT1 and NAT2) genes and smoking on bladder carcinogenesis. A literature-based systemic huge review and evidence synthesis. Am J Epidemiol 166:741–751
27. Stern MC, Lin J, Figueroa JD et al (2009) Polymorphisms in DNA repair gene, smoking, and bladder cancer risk: findings from the International Consortium of Bladder Cancer. Cancer Res 69:6857–6864